Early mortality with bispecific antibody therapy in RRMM: an IMWG immunotherapy database real-world analysis.

Blood Adv · 2026 · PMC13138148 · PMID 41734378

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

• Baseline thrombocytopenia and lack of response to bsAb were associated with early death, whereas IVIG use showed a trend toward protection.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.